Ajay Samkaria: Is Reliance on Weak D Testing Sufficient in Modern Transfusion Practice?
Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:
“Is reliance on Weak D testing sufficient in modern transfusion practice?
While preventing anti-D alloimmunization remains critical, it does not address clinically significant antibodies against other Rh antigens such as C and E.
Without extended Rh phenotyping, we risk missing these antigens – potentially leading to alloimmunization and hemolytic disease of the fetus and newborn in future pregnancies.
- Time to think beyond the D antigen.
- Comprehensive Rh phenotyping should be part of routine practice, especially in females of childbearing age.
Weak D testing addresses D antigen variability but fails to identify sensitization risks from other Rh antigens such as C and E. Undetected exposure may result in clinically significant alloantibodies, contributing to hemolytic disease of the fetus and newborn.
Extended Rh phenotyping (C, c, E, e) and antibody screening are essential strategies to improve maternal and fetal outcomes.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda